Press release

Press release

June 10, 2019

Follicum strengthens its clinical expertise in diabetes as novel peptide candidate approaches clinic – establishes Scientific Advisory Board

Follicum AB today announces the establishment of a Scientific Advisory Board in the diabetes field. The purpose is to strengthen knowledge transfer from academic research to clinical application and commercialization. The Board consists of 5 internationally reputable experts with extensive experience in research into diabetes and its complications. – By setting up a Scientific Advisory […]

May 8, 2019

Follicum receives patent grant in Europe – broadened protection for lead candidate FOL-005

Follicum has received an official grant of patent from the European Patent Office, EPO regarding the company’s broadened patent application for stimulation of hair growth. The official grant follows the “Intention to Grant” which was communicated on November 21, 2018. With EPO’s grant of patent no. EP 3087999 B1, there is now broad protection for […]

April 29, 2019

Follicum files patent application for new topical formulation of FOL-005 for hair loss

Using easy-to-apply cream instead of direct scalp injection would extend patent protection by 8 years Follicum AB (“Follicum” or “the company”) today announced that the company’s hair loss treatment projects are progressing according to plan and a patent application for an internally developed formulation of FOL-005 has been submitted. The cream formulation is intended to […]

February 11, 2019

Follicum selects novel peptide drug candidate for the treatment of diabetes and protection of beta cells

Follicum AB (“Follicum” or “the company”), a biotech company focusing on research and development of peptide-based drugs, today reports that a drug candidate has been selected for the treatment of diabetes and protection of beta cells. The drug candidate has shown unique effects in both in vitro and in vivo-models, including diabetes-related complications. The drug […]

December 5, 2018

Follicum’s diabetes project with Lund University has been awarded a Post-Doc student for 2 years for advanced studies of Follicum’s peptides

Follicum AB (“Follicum” or “Company”), a biotech company developing new peptide drugs in two areas, hair loss and diabetes, today reports that a full-time post-doc has been awarded to the diabetes project for 2 years. The aim with the project is to perform advanced experiments to further investigate the action of Follicum’s different peptide classes. […]

November 21, 2018

Follicum receives preliminary approval for patent application in Europe for extended protection of product candidate FOL-005

Follicum announced today that it has received an Intention to grant from the European Patent Office (EPO) regarding its patent application No. 16169698.4 which protects the product candidate FOL-005. In this patent family, Follicum has already a granted product patent in Europe that specifically covers FOL-005. Follicum has subsequently submitted a follow-up, a so called […]

November 12, 2018

Follicum expands patent portfolio: First diabetes patent published and promising experimental data supports new patent application

Lund, Sweden, November 12, 2018. Follicum AB (“Follicum” or “the Company”) today announced that the company’s diabetes project is progressing according to plan and that the company has submitted a new patent application. Experimental studies show that the company’s new optimized peptides exert a protective and preservative effect on beta cells exposed to high glucose […]